These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 6249910)

  • 1. Specific, high affinity [3H]ethylketocyclazocine binding in rat central nervous system: lack of evidence for kappa receptors.
    Hiller JM; Simon EJ
    J Pharmacol Exp Ther; 1980 Sep; 214(3):516-9. PubMed ID: 6249910
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nalbuphine: an autoradiographic opioid receptor binding profile in the central nervous system of an agonist/antagonist analgesic.
    De Souza EB; Schmidt WK; Kuhar MJ
    J Pharmacol Exp Ther; 1988 Jan; 244(1):391-402. PubMed ID: 2826773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differentiating aspects of opioid receptor binding by [3H](-) (1R,5R,9R,2''S)-5,9-dimethyl-2-tetrahydrofurfuryl-2'-hydroxy-6,7- benzomorphan hydrochloride ([3H]Mr 2034), a drug preferentially acting on kappa-receptors.
    Ensinger HA
    Arzneimittelforschung; 1985; 35(1A):447-51. PubMed ID: 2985096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [3H]Ethylketocyclazocine binding to mouse brain membranes: evidence for a kappa opioid receptor type.
    Garzón J; Sánchez-Blázquez P; Lee NM
    J Pharmacol Exp Ther; 1984 Oct; 231(1):33-7. PubMed ID: 6092603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple opiate binding sites in the central nervous system of the rabbit. Large predominance of a mu subtype in the cerebellum and characterization of a kappa subtype in the thalamus.
    Meunier JC; Kouakou Y; Puget A; Moisand C
    Mol Pharmacol; 1983 Jul; 24(1):23-9. PubMed ID: 6306437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Further demonstration of kappa opioid binding sites in the brain: evidence for heterogeneity.
    Su TP
    J Pharmacol Exp Ther; 1985 Jan; 232(1):144-8. PubMed ID: 2856939
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heterogeneity of opioid receptor binding in brain slices.
    Barchfeld-Rothschild CC; Medzihradsky F
    J Neurosci Res; 1987; 18(2):358-65. PubMed ID: 2891857
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distinct high-affinity binding sites for benzomorphan drugs and enkephalin in a neuroblastoma--brain hybrid cell line.
    McLawhon RW; West RE; Miller RJ; Dawson G
    Proc Natl Acad Sci U S A; 1981 Jul; 78(7):4309-13. PubMed ID: 6117074
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Opiate receptor subtypes in the rat hypothalamus and neurointermediate lobe.
    Stojilković SS; Dufau ML; Catt KJ
    Endocrinology; 1987 Jul; 121(1):384-94. PubMed ID: 3036471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Benzomorphan binding sites in rat lumbo-sacral spinal cord.
    Gouardéres C; Audigier Y; Cros J
    Eur J Pharmacol; 1982 Mar; 78(4):483-6. PubMed ID: 6281039
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [3H]Mr 2034 labels a high affinity opioid kappa-receptor not accessible to naloxazone.
    Ensinger HA
    Eur J Pharmacol; 1983 Apr; 89(1-2):143-7. PubMed ID: 6305681
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 3H-ethylketocyclazocine binding: lack of evidence for a separate kappa receptor in rats CNS.
    Hiller JM; Simon EJ
    Eur J Pharmacol; 1979 Dec; 60(4):389-90. PubMed ID: 230985
    [No Abstract]   [Full Text] [Related]  

  • 13. Evidence for multiple "Kappa" binding sites by use of opioid peptides in the guinea-pig lumbo-sacral spinal cord.
    Attali B; Gouardères C; Mazarguil H; Audigier Y; Cros J
    Neuropeptides; 1982 Oct; 3(1):53-64. PubMed ID: 6296719
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Naloxone-inaccessible sigma receptor in rat central nervous system.
    Tam SW
    Proc Natl Acad Sci U S A; 1983 Nov; 80(21):6703-7. PubMed ID: 6314335
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple opiate receptors: [3H]ethylketocyclazocine receptor binding and ketocyclazocine analgesia.
    Pasternak GW
    Proc Natl Acad Sci U S A; 1980 Jun; 77(6):3691-4. PubMed ID: 6251477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [3H]ethylketocyclazocine binding to NCB-20 hybrid neurotumor cells.
    West RE; McLawhon RW; Dawson G; Miller RJ
    Mol Pharmacol; 1983 Mar; 23(2):486-92. PubMed ID: 6339880
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction between [3H]ethylketocyclazocine and [3H]etorphine and opioid receptors in membranes from rat brain. A kinetic analysis.
    Fischel SV; Medzihradsky F
    Neuropharmacology; 1986 Apr; 25(4):351-9. PubMed ID: 3012397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Solubilization and preliminary characterization of mu and kappa opiate receptor subtypes from rat brain.
    Chow T; Zukin RS
    Mol Pharmacol; 1983 Sep; 24(2):203-12. PubMed ID: 6310362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of specific binding sites for [3H](d)-N-allylnormetazocine in rat brain membranes.
    Itzhak Y; Hiller JM; Simon EJ
    Mol Pharmacol; 1985 Jan; 27(1):46-52. PubMed ID: 3965930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characteristics of opioid receptors in guinea-pig cerebellum and human placenta.
    Ishizuka Y; Oka T; Kenjo T; Fujii A
    Tokai J Exp Clin Med; 1986 Aug; 11(3):179-84. PubMed ID: 3039693
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.